<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      HIV & ART General Concepts
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/hiv-art-general-concepts" data-history-node-id="2558" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div class="WordSection1">
        <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 2.0pt 0in">
         <p style="border:none; padding:0in">
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 HIV/AIDS and ART – Joseph Quintana
                </span>
               </span>
              </b>
             </span>
            </span>
           </span>
          </span>
         </p>
        </div>
        <p>
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Background
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Why is ART important?
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Clear morbidity and mortality benefits across all CD4 counts
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Decreases subsequent infections (both common and opportunistic)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Decreased HIV related comorbid conditions and viral reservoirs
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Reduced HIV transmission
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Long term improvement in immune cell function and activation
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Most patients will have their care at Comprehensive care clinic (CCC), the Vanderbilt HIV clinic, and these clinicians staff Rogers ID and HIV consult service
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  New HIV Diagnosis
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    ID consult (important for initiation, follow up [CCC], social work assistance)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    ART is indicated for all HIV+ patients, regardless of CD4; however, starting ART requires appropriate outpatient follow up
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Lab evaluation:
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    HIV viral load, genotype and resistance testing
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    T cell subsets (CD4 Count)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    HLA*B5701 testing before using abacavir containing regimen
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    CBC with differential, CMP, UA
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    T-Spot
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Pregnancy testing
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Viral hepatitis serologies
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Toxoplasma serologies
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Other STI screening (Syphilis, Gonorrhea/chlamydia)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Timing of ART initiation
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Engage ID, address social barriers, baseline laboratory evaluation, arrange follow up
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Factors affecting timing
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Drug toxicity and interactions, risks for resistance, adherence
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Barriers to medication adherence (homelessness, substance use disorder, behavioral health diagnosis)
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Treatment of opportunistic infections may delay initiation of ART given associated risk of immune reconstitution inflammatory syndrome (IRIS)
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Delay ART for several weeks after initiation of therapy for cryptococcal meningitis, in which IRIS can be fatal
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
            </ul>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  ART plan for overnight admits
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="background:white">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Okay to continue home ART, special consideration for:
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Pts with hepatic or renal dysfunction, may need dose adjustment
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      If there is concern for non-adherence, can hold morning dose
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Can be discussed with ID/outpt provider in the morning
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="page:WordSection1">
               <span style="font-size:11pt">
                <span style="line-height:normal">
                 <span style="font-family:Calibri,sans-serif">
                  <span style="font-size:12.0pt">
                   <span style="background:white">
                    <span style="font-family:Palatino">
                     <span style="color:black">
                      Combination pills may need to be ordered as the separate components
                     </span>
                    </span>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
            </ul>
           </li>
          </ul>
         </li>
         <li>
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="background:white">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Common key regimens for initiation
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="background:white">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Most regimens consist of an NRTI backbone (2 agents) plus a 3
                   <sup>
                    rd
                   </sup>
                   agent
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="background:white">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Many patients are started on combination pill regimens, including Integrase Inhibitor based regimens: Biktarvy®, Triumeq®, dolutegravir + Descovy®
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li>
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="line-height:107%">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Dolutegravir and bictegravir have high barriers to resistance relative to first-generation integrase inhibitors elvitegravir and raltegravir
                  </span>
                 </span>
                </span>
               </span>
              </span>
              <br/>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
       </div>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>